RNA sequencing and qPCR cohort | qPCR and IH cohort | |||||
---|---|---|---|---|---|---|
CD group | CTR group (MAT) | CTR group (ileal mucosa) | CD group | CTR group (MAT) | CTR group (ileal mucosa) | |
Number | 8 | 4 | 4 | 18 | 13 | 8 |
Gender (M/F) | 4/4 | 2/2 | 2/2 | 6/12 | 4/9 | 2/6 |
Age (years) | 38 [20–66] | 64.5 [58–67]# | 57.5 [44–60] | 36 [20–70] | 56 [26–61] | 57 [44–71]# |
Disease duration (years) | 6 [1–14] | – | – | 6.5 [1–30] | – | – |
Age at diagnosis (A1/A2/A3)a | 1/5/2 | – | – | 1/14/3 | – | – |
Location (L1/L2/L3/L4)a | 4/0/4/0 | – | – | 5/0/13/0 | – | – |
Behaviour (B1/B2/B3)a | 0/3/5 | – | – | 0/12/6 | – | – |
Perianal disease (yes/no) | 1/7 | – | – | 2/16 | – | – |
Immunosuppressant (yes/no) | 5/3 | – | – | 7/11 | – | – |
Anti-TNFα therapy (yes/no) | 8/0 | – | – | 18/0 | – | – |
CDAI | 301.9 [261.4–609.6] | – | – | 325.5 [162–479.8] | – | – |
Presence of ulcers (yes/no) | 8/0b | 0/4c | 0/4c | 18/0b | 0/13c | 0/8c |
Body weight (kg) | 58 [48–79] | 60 [52–63] | 65.8 [54–72.6] | 56.5 [43.4–78] | 74 [49–107] | 72 [58–98] |
Body mass index | 22.7 [15.5–26.5] | 21 [20.8–21.5] | 26.8 [24–29.6] | 21.4 [14.7–30.4] | 29.7 [21.2–36.1] | 25.5 [22.7–38] |